Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - Discontinued
Roche (RHHBY) Provides Update On Gantenerumab Development Programme 12/19/2014 6:07:34 AM
H. Lundbeck A/S (LUN.CO) Will Halt Studies Into Vampire Bat Saliva Drug 12/18/2014 9:26:03 AM
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/6/2014 7:56:55 AM
Trial Failures Force Eli Lilly and Company (LLY) To Terminate Development Of Tabalumab 10/2/2014 6:42:29 AM
Traders Wobble On Merck KGaA (MKGAF.PK) After Stimuvax Stop 9/12/2014 7:00:39 AM
Bay Area's Hyperion Therapeutics (HPTX) Tanks As Employee Misconduct Leads To Drug Trial Halt 9/8/2014 7:04:34 AM
Second Failure Of The Month As Targacept, Inc. (TRGT) Halts Development Of Bladder Drug, Shares Plunge 7/29/2014 5:57:49 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/19/2014 6:09:16 AM
Johnson & Johnson (JNJ) Halts Development Of Botox Rival, Axes Staffers 4/14/2014 7:14:10 AM
Forest Laboratories, Inc. (FRX) To Discontinue NAMENDA® Tablets, Focus On Once-Daily NAMENDA XR® 2/17/2014 6:32:23 AM
Sanofi (France) (SAN.PA) Suffers Another Setback, Ditches Late-Stage Bone Marrow Cancer Drug 11/18/2013 7:03:54 AM
Imprimis Pharmaceuticals (immy) to Shift Focus, Discontinues Impracor Phase 3 Program to Focus on Other Areas 11/6/2013 9:06:43 AM
ImmunoGen, Inc. (IMGN) Discontinues Study as Lung Cancer Drug Flops; Stock Crashes -18.97%% at Market Close (November 5, 2013) 11/5/2013 7:22:00 AM
Ariad Pharmaceuticals, Inc. (ARIA) Discontinues Phase 3 Study of Cancer Drug Iclusig; Shares Decimated, Falls -40.67% at Market Close (October 18, 2013) 10/18/2013 8:07:51 AM
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013 6:54:34 AM